Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qi-Deng Ming-Mu Capsule for diabetic macular edema
ChiCTR1900026692Phase 2Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Qi-Deng Ming-Mu capsule in diabetic macular edema (DME) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Mean change in BCVA score. Started Oct 2019; status: recruiting.
02
Drugs
Qi-Deng Ming-Mu capsule
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ChiCTR1900026692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026692.